Looking to read the latest press release or want to see what conference Next Breath will be exhibiting at next? Check here for information on the latest news and happenings.
|Mar. 19-21, 2018||2018 PDA Annual Meeting||Orlando, FL|
|Apr. 12-13, 2018||Nasal Drug Delivery||London, UK|
|Apr. 22-26, 2018||Respiratory Drug Delivery (RDD18)||Tucson, AZ|
|May 7-9, 2018||Extracatables & Leachables US 2018||Bethesda, MD|
|Oct. 3-4, 2018||Medicon Valley Inhalation Consortium (MVIC Symposium)||Lund, Sweden|
|Dec. 2018||Drug Delivery to the Lung (DDL18)||Edinburgh, Scotland|
Baltimore, Maryland – January 19, 2018. Next Breath, a division of AptarGroup, Inc., is pleased to announce the extension of their cGMP analytical services to include development services for injectable delivery systems, with a core focus on extractables and leachables.
Brazilian National Sanitary Surveillance Agency (ANVISA) Certifies Next Breath as a Center for In Vitro Pharmaceutical Equivalence
Baltimore, USA – March 28th, 2014 - Next Breath is pleased to announce that the Brazilian National Sanitary Surveillance Agency (ANVISA) has certified the company as a Center for Pharmaceutical Equivalence (EQFAR). As a result, Next Breath is now authorized to conduct Pharmaceutical Equivalence studies for Brazil. ANVISA performed a week-long comprehensive audit of Next Breath’s quality systems in November [...]